
Number of publications published per year by Shimomura, Soji. (Source : PubMed)

Distribution of publications types for Shimomura, Soji. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)
Vitamin K2 downregulates the expression of fibroblast growth factor receptor 3 in human hepatocellular carcinoma cells.
Hepatol. Res.
2009;39;11
Hepatoma-derived growth factor is induced in liver regeneration.
Hepatol. Res.
2009;39;10
Involvement of hepatoma-derived growth factor in the growth inhibition of hepatocellular carcinoma cells by vitamin K(2).
J. Gastroenterol.
2009;44;3
Vitamin K2 inhibits the proliferation of HepG2 cells by up-regulating the transcription of p21 gene.
Hepatol. Res.
2007;37;5
Chemoprevention of spontaneous development of hepatocellular carcinomas in fatty liver Shionogi mice by a cyclooxygenase-2 inhibitor.
Cancer Sci.
2006;97;8

Hemochromatosis with mutation of the ferroportin 1 (IREG1) gene.
Intern. Med.
2005;44;4
Evaluation of interleukin-12-induced interferon-y production in vitro by peripheral blood mononuclear cells in patients with chronic liver disease.
Hepatogastroenterology
2003;50;53
Expression of cyclooxygenase 2 and cytosolic phospholipase A(2) in the liver tissue of patients with chronic hepatitis and liver cirrhosis.
Hepatol. Res.
2002;23;3
Investigation of TTV by in situ hybridization in patients with chronic hepatitis.
Hepatol. Res.
2000;18;1
Laparoscopic prediction of hepatocellular carcinoma in cirrhosis patients.
J. Gastroenterol. Hepatol.
1997;12;8
[ See timeline ] [ See all publications ]
means that Shimomura, Soji has 6 papers cited a least 6 times - methodology
Division of Hepatobiliary and Pancreatic Medicine, Department of Internal Medicine, Hyogo College of Medicine, Nishinomiya, Hyogo, Japan.
Due mainly to homonyms, errors are possible and if you detect "false positives" or "false negatives" don't be too frustrated and please contact the webmaster.